Speciality: CritiCare Prabinex
Description:
In today's episode, we explore the latest advances in monitoring technology for critically ill patients. Modern intensive care units now use sophisticated tools like continuous EEG, advanced hemodynamic monitoring, and real-time blood gas analysis. These innovations allow healthcare teams to detect subtle changes in a patient’s condition much earlier, leading to faster, more precise interventions. With wearable devices and wireless sensors, clinicians can monitor vital signs remotely, reducing the risk of infection and improving patient comfort. As artificial intelligence and predictive analytics become more integrated, we can expect even earlier warning systems for complications. These advances are transforming critical care, making it safer and more effective for those who need it most.
See More Webinars @ Hidoc Webinars
1.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
2.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
3.
Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers
4.
Adjuvant Combination for Kidney Cancer Gets FDA's Blessing
5.
TKI Discontinuation Feasible After ALL Treatment
1.
Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer
2.
Importance of Early Detection in Hematology
3.
Reproductive Hormones and Immune Cell Metabolism: Mechanisms, Clinical Implications, and Emerging Evidence
4.
Clonal Hematopoiesis as a Mechanism of Age-Related Disease
5.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
4.
Expert Perspectives on Hematology
5.
Screening for Red Cell Membrane Disorders Through Ektacytometry-Based Deformability Profiling
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation